MRSN logo

Mersana Therapeutics (MRSN)

Profile

Full Name

Mersana Therapeutics, Inc.

Ticker Symbol

MRSN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 28, 2017

Indexes

Not included

Website

http://www.mersana.com

Employees

102

Key Details

Price

$0.35(+5.20%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$40.50M(+9.88% YoY)

Annual EPS

-$0.56(+62.16% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.35
MRSN price is $0.35

30-Day Relative Volume

1.19
MRSN 30-day relative volume is 1.19

Price Performance

Price Today change

+5.2%
MRSN price is up +5.2% today

Price YTD change

-75.65%
MRSN price is down -75.65% since January 1st

Price 1-year change

-90.81%
MRSN price is down -90.81% year-on-year

Price 3-year change

-92.91%
MRSN price is down -92.91% over the past 3 years

Price Range

Price All-time high

$29.09
MRSN price is currently -98.80% below its historical high of $29.09

Price 3-year low

$0.26
MRSN price is currently +34.44% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$43.40M
MRSN market capitalization is $43.40 million

Market cap 3-year change

-90.64%
MRSN market capitalization is down -90.64% over the past 3 years

Market cap All-time high

$1.89B
MRSN market capitalization is currently -97.70% below its historical high of $1.89 billion

Market cap sector rank

36.27%
MRSN market capitalization is higher than 36.27% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.86%
MRSN shares outstanding is up +1.86% year-on-year

Shares Outstanding 3-Year Change

+31.93%
MRSN shares outstanding is up +31.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.88
MRSN beta is 1.88

200-day SMA

$1.45
MRSN price is currently -75.94% below its 200-day simple moving average

50-day SMA

$0.48
MRSN price is currently -27.82% below its 50-day simple moving average

RSI

40.08
MRSN 14-day relative strength index is 40.08

Volume

1.19
MRSN 30-day relative volume is 1.19

ATR

$0.05
MRSN average true range is $0.05

10-day Historical Volatility

145.01%
MRSN 10-day historical volatility is 145.01%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$40.50M
MRSN annual revenue is $40.50 million

Revenue Analysts estimate

$27.62M
MRSN annual revenue is currently +46.60% higher than the consensus analysts' forecast

Revenue 1-year change

+9.88%
MRSN annual revenue is up +9.88% year-on-year

Revenue Sector rank

44.12%
MRSN annual revenue is higher than 44.12% of companies in Healthcare sector

EPS

EPS

-$0.56
MRSN annual earnings per share is -$0.56

EPS Analysts estimate

-$0.79
MRSN annual earnings per share is currently -29.29% lower than the consensus analysts' forecast

EPS 1-year change

+62.16%
MRSN annual earnings per share is up +62.16% year-on-year

EPS Sector rank

66.91%
MRSN annual earnings per share is higher than 66.91% of companies in Healthcare sector

Profit

Gross profit

-
MRSN annual gross profit value is unknown

Gross margin

-
MRSN annual gross profit margin value is unknown

Operating profit

-$73.34M
MRSN annual operating income is -$73.34 million

Operating margin

-181.09%
MRSN annual operating profit margin is -181.09%

Net income

-$69.19M
MRSN annual net profit is -$69.19 million

Net margin

-170.86%
MRSN annual net profit margin is -170.86%

Expenses

Total expenses

$113.83M
MRSN annual total expenses is $113.83 million

Operating expenses

$113.83M
MRSN annual total operating expenses is $113.83 million

Cost of goods sold

-
MRSN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$40.81M
MRSN annual SGA is $40.81 million

Depreciation and amortization

$1.63M
MRSN annual depreciation & amortization is $1.63 million

Interest expense

$3.87M
MRSN annual interest expense is $3.87 million

Income tax

$418.00K
MRSN annual income tax is $418.00 thousand

EBIT & EBITDA

EBIT

-$64.90M
MRSN annual earnings before interest & taxes is -$64.90 million

EBITDA

-$63.27M
MRSN annual EBITDA is -$63.27 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$144.66M
MRSN annual total assets is $144.66 million

Non current assets

$7.76M
MRSN annual long term assets is $7.76 million

Current assets

$136.90M
MRSN annual total current assets is $136.90 million

Cash and cash equivalents

$107.75M
MRSN annual cash & cash equivalents is $107.75 million

Accounts receivable

-
MRSN annual accounts receivable value is unknown

Inventory

-
MRSN annual inventory value is unknown

Liabilities

Total liabilities

$154.17M
MRSN annual total liabilities is $154.17 million

Long term liabilities

$91.71M
MRSN annual total long term liabilities is $91.71 million

Current liabilities

$62.46M
MRSN annual total current liabilities is $62.46 million

Accounts payable

$4.33M
MRSN annual accounts payable is $4.33 million

Debt

Total debt

$28.60M
MRSN annual total debt is $28.60 million

Total debt 1-year change

-14.97%
MRSN annual total debt is down -14.97% year-on-year

Long term debt

$12.24M
MRSN annual long term debt is $12.24 million

Short term debt

$16.36M
MRSN annual short term debt is $16.36 million

Equity & Capital

Shareholders equity

-$9.51M
MRSN annual stockholders equity is -$9.51 million

Book value

-$9.51M
MRSN annual book value is -$9.51 million

Retained earnings

-$895.55M
MRSN annual retained earnings is -$895.55 million

Working capital

$74.45M
MRSN annual working capital is $74.45 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$82.34M
MRSN annual cash flow from operations is -$82.34 million

Cash from operations 1-year change

+51.24%
MRSN annual cash flow from operations is up +51.24% year-on-year

Cash from investing

$11.44M
MRSN annual cash flow from investing activities is $11.44 million

Cash from investing 1-year change

-90.46%
MRSN annual cash flow from investing activities is down -90.46% year-on-year

Cash from financing

$4.09M
MRSN annual cash flow from financing activities is $4.09 million

Cash from financing 1-year change

-95.68%
MRSN annual cash flow from financing activities is down -95.68% year-on-year

CAPEX

CAPEX

$132.00K
MRSN annual capital expenditures is $132.00 thousand

CAPEX 1-year change

-93.91%
MRSN annual capital expenditures is down -93.91% year-on-year

Free Cash Flow

Free cash flow

-$82.47M
MRSN annual free cash flow is -$82.47 million

Free cash flow 1-year change

+51.78%
MRSN annual free cash flow is up +51.78% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MRSN annual gross profit margin value is unknown

Operating margin

-181.09%
MRSN annual operating profit margin is -181.09%

Net margin

-170.86%
MRSN annual net profit margin is -170.86%

ROA & ROE

ROA

-37.33%
MRSN annual return on assets is -37.33%

ROE

-505.14%
MRSN annual return on equity is -505.14%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MRSN price to earnings ratio value is unknown

PE ratio Sector rank

-
MRSN price to earnings ratio is unknown

PB Ratio

PB ratio

-4.56
MRSN price to book ratio is -4.56

PB ratio Sector rank

4.03%
MRSN price to book ratio is higher than 4.03% of companies in Healthcare sector

PS Ratio

PS ratio

1.07
MRSN price to sales ratio is 1.07

PS ratio Sector rank

28.33%
MRSN price to sales ratio is higher than 28.33% of companies in Healthcare sector

Enterprise value

Enterprise value

-$35.76M
MRSN enterprise value is -$35.76 million

Enterprise value Sector rank

2.23%
MRSN enterprise value is higher than 2.23% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.57
MRSN EV/EBITDA is 0.57

EV/EBITDA Sector rank

72.78%
MRSN EV/EBITDA is higher than 72.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.19
MRSN annual current ratio is 2.19

Quick ratio

-
MRSN annual quick ratio value is unknown

Leverage

Debt to equity

-2.47
MRSN annual debt to equity ratio is -2.47

Interest coverage ratio

-16.75
MRSN annual interest coverage ratio is -16.75

Risk & Stability

Piotroski F-Score

-
MRSN piotroski f-score value is unknown

Altman Z-Score

-9.08
MRSN altman z-score is -9.08

Analyst ratings

Recent major analysts updates

Feb 6, 25 William Blair
Outperform
Aug 27, 24 Citigroup
Buy
Aug 14, 24 Baird
Neutral
Mar 19, 24 JP Morgan
Neutral
Feb 29, 24 Wedbush
Outperform
Feb 29, 24 Truist Securities
Buy
Feb 29, 24 Guggenheim
Buy
Feb 29, 24 Baird
Neutral
Dec 4, 23 Citigroup
Buy
Aug 8, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

RANI logo
Rani Therapeutics Holdings (RANI)
ATNM logo
Actinium Pharmaceuticals (ATNM)
OPGN logo
OpGen (OPGN)
STTK logo
Shattuck Labs (STTK)
SKYE logo
Skye Bioscience (SKYE)
ARMP logo
Armata Pharmaceuticals (ARMP)
APYX logo
Apyx Medical (APYX)
AADI logo
Aadi Bioscience (AADI)
ECOR logo
electroCore (ECOR)
  • What is the ticker symbol for Mersana Therapeutics?
  • Does Mersana Therapeutics pay dividends?
  • What sector is Mersana Therapeutics in?
  • What industry is Mersana Therapeutics in?
  • What country is Mersana Therapeutics based in?
  • When did Mersana Therapeutics go public?
  • Is Mersana Therapeutics in the S&P 500?
  • Is Mersana Therapeutics in the NASDAQ 100?
  • Is Mersana Therapeutics in the Dow Jones?
  • When was Mersana Therapeutics's last earnings report?
  • When does Mersana Therapeutics report earnings?
  • Should I buy Mersana Therapeutics stock now?

What is the ticker symbol for Mersana Therapeutics?

The ticker symbol for Mersana Therapeutics is NASDAQ:MRSN

Does Mersana Therapeutics pay dividends?

No, Mersana Therapeutics does not pay dividends

What sector is Mersana Therapeutics in?

Mersana Therapeutics is in the Healthcare sector

What industry is Mersana Therapeutics in?

Mersana Therapeutics is in the Biotechnology industry

What country is Mersana Therapeutics based in?

Mersana Therapeutics is headquartered in United States

When did Mersana Therapeutics go public?

Mersana Therapeutics's initial public offering (IPO) was on June 28, 2017

Is Mersana Therapeutics in the S&P 500?

No, Mersana Therapeutics is not included in the S&P 500 index

Is Mersana Therapeutics in the NASDAQ 100?

No, Mersana Therapeutics is not included in the NASDAQ 100 index

Is Mersana Therapeutics in the Dow Jones?

No, Mersana Therapeutics is not included in the Dow Jones index

When was Mersana Therapeutics's last earnings report?

Mersana Therapeutics's most recent earnings report was on Mar 3, 2025

When does Mersana Therapeutics report earnings?

The next expected earnings date for Mersana Therapeutics is May 9, 2025

Should I buy Mersana Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page